Is it only for weight loss
The 12 mg weekly dose problem: when 30 mg vials get awkward A patient titrated to the upper Phase 2 retatrutide dose (12 mg weekly) and using a 30 mg vial faces a constraint: the dose volume needs to stay inside one U-100 syringe
comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study
Carrying fast-acting glucose during workouts is standard practice
Compounded tirzepatide (vials): Like compounded semaglutide, compounded tirzepatide must be refrigerated at all times
These metabolic pathways, rather than a direct anti-proliferative action, may be the target as Metformin decreases hepatic gluconeogenesis, improves insulin sensitivity, reduces insulin and blood glucose levels, and these effects, which also will reduce tumor growth, rather than a direct anti-proliferative action may be the primary target of metformin (55, 248)